Cardiovascular DiseasesDisease Models, AnimalRisk FactorsHypertensionAtherosclerosisBiological MarkersCohort StudiesBlood PressureRisk AssessmentProspective StudiesInflammationMice, Inbred C57BLMetabolic Syndrome XObesityFollow-Up StudiesCross-Sectional StudiesDiabetes Mellitus, Type 2PrevalenceDiabetes MellitusTime FactorsDyslipidemiasBody Mass IndexC-Reactive ProteinProportional Hazards ModelsIncidenceCholesterolLipidsSex FactorsSmokingUnited StatesOxidative StressAge FactorsCause of DeathLife StyleCoronary DiseaseHomocysteineMice, KnockoutCholesterol, HDLSignal TransductionCells, CulturedCholesterol, LDLDietRiskStrokePrimary PreventionMice, TransgenicDiabetes ComplicationsDiabetic AngiopathiesEndothelium, VascularModels, BiologicalTriglyceridesCase-Control StudiesPhenotypeKidney Failure, ChronicBlood GlucoseCardiovascular SystemMyocardial InfarctionHyperlipidemiasChronic DiseaseAgingKidney DiseasesHypercholesterolemiaGenetic Predisposition to DiseaseHydroxymethylglutaryl-CoA Reductase InhibitorsHuntington DiseaseJapanHypolipidemic AgentsPredictive Value of TestsNeurodegenerative DiseasesInsulin ResistanceGene Expression RegulationTreatment OutcomeCarotid Intima-Media ThicknessCoronary Artery DiseaseMortalityNeoplasmsComorbiditySex DistributionMultivariate AnalysisCalcinosisAntioxidantsDisease ProgressionExerciseAntihypertensive AgentsAnalysis of VarianceCarotid ArteriesVascular DiseasesRisk Reduction BehaviorPolymorphism, Single NucleotideLongitudinal StudiesEuropean Continental Ancestry GroupArteriosclerosisCardiovascular AgentsRats, Sprague-DawleyRegression AnalysisGenotypeLinear ModelsAge DistributionQuestionnairesNeuroprotective Agents